# Lenalidomide in Kaposi Disease Associated With HIV Infection

> **NCT01282047** · PHASE2 · TERMINATED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 12 (actual)

## Conditions studied

- HIV Infection Associated Kaposi Disease

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT01282047
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282047, "Lenalidomide in Kaposi Disease Associated With HIV Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01282047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*